141 related articles for article (PubMed ID: 22857389)
1. Spontaneous remission of juvenile myelomonocytic leukemia with NRAS mutation.
Alsultan A; Khalifah M; Alrabiaah AA
Pediatr Hematol Oncol; 2012 Oct; 29(7):624-6. PubMed ID: 22857389
[No Abstract] [Full Text] [Related]
2. [Molecular mechanism and progress in treatment of juvenile myelomonocytic leukemia (JMML)].
Koike K; Matsuda K
Rinsho Ketsueki; 2013 Jun; 54(6):538-44. PubMed ID: 23823092
[No Abstract] [Full Text] [Related]
3. [Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].
Manabe A
Rinsho Ketsueki; 2012 Aug; 53(8):729-33. PubMed ID: 22975811
[No Abstract] [Full Text] [Related]
4. Acquisition of loss of the wild-type NRAS locus with aggressive disease progression in a patient with juvenile myelomonocytic leukemia and a heterozygous NRAS mutation.
Matsuda K; Nakazawa Y; Sakashita K; Shiohara M; Yamauchi K; Koike K
Haematologica; 2007 Nov; 92(11):1576-8. PubMed ID: 18024411
[TBL] [Abstract][Full Text] [Related]
5. Concurrent juvenile myelomonocytic leukemia and T-lymphoblastic lymphoma with a shared missense mutation in NRAS.
Ly B; Modi A; Rogers HJ; Makishima H; Hanna R; Cook JR; Theil KS; Maciejewski JP
Pediatr Blood Cancer; 2014 May; 61(5):946-8. PubMed ID: 24610751
[TBL] [Abstract][Full Text] [Related]
6. Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia.
De Filippi P; Zecca M; Lisini D; Rosti V; Cagioni C; Carlo-Stella C; Radi O; Veggiotti P; Mastronuzzi A; Acquaviva A; D'Ambrosio A; Locatelli F; Danesino C
Br J Haematol; 2009 Dec; 147(5):706-9. PubMed ID: 19775298
[TBL] [Abstract][Full Text] [Related]
7. [Molecular biology of juvenile myelomonocytic leukemia (JMML)].
Manabe A
Rinsho Ketsueki; 2010 Jul; 51(7):526-31. PubMed ID: 20693772
[No Abstract] [Full Text] [Related]
8. The strange case of the lost NRAS mutation in a child with juvenile myelomonocytic leukemia.
De Filippi P; Zecca M; Novara F; Lisini D; Maserati E; Pasquali F; Rosti V; Carlo-Stella C; Zavras N; Cagioni C; Zuffardi O; Pagliara D; Danesino C; Locatelli F
Pediatr Blood Cancer; 2012 Sep; 59(3):580-2. PubMed ID: 22183880
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of juvenile myelomonocytic leukemia.
de Vries AC; Zwaan CM; van den Heuvel-Eibrink MM
Haematologica; 2010 Feb; 95(2):179-82. PubMed ID: 20139388
[No Abstract] [Full Text] [Related]
10. Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML.
Takagi M; Piao J; Lin L; Kawaguchi H; Imai C; Ogawa A; Watanabe A; Akiyama K; Kobayashi C; Mori M; Ko K; Sugimoto M; Mizutani S
Leukemia; 2013 Sep; 27(9):1926-8. PubMed ID: 23503607
[No Abstract] [Full Text] [Related]
11. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia.
Koike K; Matsuda K
Br J Haematol; 2008 May; 141(5):567-75. PubMed ID: 18422786
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of juvenile myelomonocytic leukemia.
Sakashita K; Matsuda K; Koike K
Pediatr Int; 2016 Aug; 58(8):681-90. PubMed ID: 27322988
[TBL] [Abstract][Full Text] [Related]
13. [Myelodysplastic syndrome in children].
Yoshimi-Noellke A
Rinsho Ketsueki; 2009 Oct; 50(10):1560-9. PubMed ID: 19915367
[No Abstract] [Full Text] [Related]
14. Control of thrombotic thrombocytopenic purpura by sirolimus in a child with juvenile myelomonocytic leukemia and somatic N-RAS mutation.
Maschan M; Bobrynina V; Khachatryan L; Kalinina I; Solopova G; Avdonin P; Nasedkina T; Novichkova G; Maschan A
Pediatr Blood Cancer; 2014 Oct; 61(10):1871-3. PubMed ID: 24590757
[TBL] [Abstract][Full Text] [Related]
15. Trissomy of chromosome 8 and juvenile myelomonocytic leukemia.
Valera ET; Brassesco MS; Scrideli CA; Tone LG
J Pediatr Hematol Oncol; 2012 May; 34(4):e170-1. PubMed ID: 22531497
[No Abstract] [Full Text] [Related]
16. Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia.
Yoshida N; Yagasaki H; Xu Y; Matsuda K; Yoshimi A; Takahashi Y; Hama A; Nishio N; Muramatsu H; Watanabe N; Matsumoto K; Kato K; Ueyama J; Inada H; Goto H; Yabe M; Kudo K; Mimaya J; Kikuchi A; Manabe A; Koike K; Kojima S
Pediatr Res; 2009 Mar; 65(3):334-40. PubMed ID: 19047918
[TBL] [Abstract][Full Text] [Related]
17. Juvenile myelomonocytic leukemia with less aggressive clinical course and KRAS mutation.
Imamura M; Imai C; Takachi T; Nemoto T; Tanaka A; Uchiyama M
Pediatr Blood Cancer; 2008 Oct; 51(4):569. PubMed ID: 18561174
[No Abstract] [Full Text] [Related]
18. [Gene mutations and clinical characteristics in children with juvenile myelomonocytic leukemia].
Yang WY; Chen XJ; Wang SC; Guo Y; Liu TF; Chang LX; Liu F; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):1-5. PubMed ID: 25616283
[TBL] [Abstract][Full Text] [Related]
19. Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.
Raikar SS; Scarborough JD; Sabnis H; Bergsagel J; Wu D; Cooper TM; Keller FG; Wood BL; Bunting ST
Pediatr Blood Cancer; 2016 Sep; 63(9):1667-70. PubMed ID: 27145535
[TBL] [Abstract][Full Text] [Related]
20. Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia.
Loh ML
Hematology Am Soc Hematol Educ Program; 2010; 2010():357-62. PubMed ID: 21239819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
